Node Smith, ND On April 19, 2018, an advisory panel from the Federal Food and Drug Administration (FDA) recommended a new drug to be approved for the treatment of epilepsy.1 The drug, Epidiolex, produced by GW Pharmaceuticals in Britain, is a pure oral solution of...

Node Smith, ND A recent study calls into question the current recommended guidelines for screening for prediabetes and type 2 diabetes.1 The current recommendations advocate screening for diabetes based on only age and weight, which could be missing up to half (50%)...